Treace Medical Concepts, Inc. Line of Credit Facility, Unused Capacity, Commitment Fee Percentage
Treace Medical Concepts, Inc. (TMCI) had Line of Credit Facility, Unused Capacity, Commitment Fee Percentage of 0.50% as of 2025-12-17, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt
us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage · last filed 2026-08-07
- 2025-12-17: Line of Credit Facility, Unused Capacity, Commitment Fee Percentage 0.50%.
| Period end | Line of Credit Facility, Unused Capacity, Commitment Fee Percentage |
|---|---|
| 2025-12-17 | 0.50% 10-Q · filed 2026-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |